In conclusion, our study indicates that automated HER2/CEP17 FISH is a reliable in situ method to analyse the HER2 amplification status and in the future may represent a clinically useful tool for standardised and objective HER2 status evaluation of carcinoma cells, especially in combination with automated image analysis tools. The gene discussed is ERBB2; the disease is carcinoma.